|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 304.33 USD | -0.84% |
|
+9.76% | -7.81% |
| 09/04 | Piper Sandler Adjusts Price Target on UnitedHealth to $399 From $390, Maintains Overweight Rating | MT |
| 08/04 | US stocks end mixed on signs of progress before Trump's Iran deadline | RE |
Company Valuation: UnitedHealth Group Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 4,72,941 | 4,95,373 | 4,86,945 | 4,65,535 | 2,99,026 | 2,76,233 | - | - |
| Change | - | 4.74% | -1.7% | -4.4% | -35.77% | -7.62% | - | - |
| Enterprise Value (EV) 1 | 4,95,037 | 5,14,300 | 5,19,854 | 5,13,326 | 3,49,294 | 3,22,002 | 3,19,574 | 3,16,920 |
| Change | - | 3.89% | 1.08% | -1.26% | -31.95% | -7.81% | -0.75% | -0.83% |
| P/E ratio | 27.8x | 25x | 22.1x | 32.6x | 25x | 18.1x | 16.2x | 13.6x |
| PBR | 6.28x | 6.18x | 5.48x | 5x | - | 2.59x | 2.43x | 2.25x |
| PEG | - | 1.5x | 1.7x | -0.9x | -1.7x | 0.7x | 1.4x | 0.7x |
| Capitalization / Revenue | 1.64x | 1.53x | 1.31x | 1.16x | 0.67x | 0.63x | 0.6x | 0.57x |
| EV / Revenue | 1.72x | 1.59x | 1.4x | 1.28x | 0.78x | 0.73x | 0.7x | 0.65x |
| EV / EBITDA | 18.3x | 16.2x | 14.3x | 14.1x | 15x | 11.6x | 10.6x | 9.05x |
| EV / EBIT | 20.7x | 18.1x | 16.1x | 15.9x | 18.4x | 13.6x | 12.4x | 10.5x |
| EV / FCF | 24.9x | 22x | 20.2x | 24.8x | 21.7x | 19x | 19.6x | 16.6x |
| FCF Yield | 4.02% | 4.55% | 4.94% | 4.03% | 4.6% | 5.27% | 5.09% | 6.02% |
| Dividend per Share 2 | 5.6 | 6.4 | 7.29 | 8.18 | - | 8.802 | 9.276 | 9.895 |
| Rate of return | 1.12% | 1.21% | 1.38% | 1.62% | - | 2.89% | 3.05% | 3.25% |
| EPS 2 | 18.08 | 21.18 | 23.86 | 15.51 | 13.23 | 16.79 | 18.73 | 22.32 |
| Distribution rate | 31% | 30.2% | 30.6% | 52.7% | - | 52.4% | 49.5% | 44.3% |
| Net sales 1 | 2,87,597 | 3,24,162 | 3,71,622 | 4,00,278 | 4,47,567 | 4,41,685 | 4,57,120 | 4,84,221 |
| EBITDA 1 | 27,073 | 31,835 | 36,330 | 36,386 | 23,325 | 27,750 | 30,173 | 35,000 |
| EBIT 1 | 23,970 | 28,435 | 32,358 | 32,287 | 18,964 | 23,692 | 25,698 | 30,133 |
| Net income 1 | 17,285 | 20,120 | 22,381 | 14,405 | 12,056 | 15,199 | 17,208 | 20,187 |
| Net Debt 1 | 22,096 | 18,927 | 32,909 | 47,791 | 50,268 | 45,769 | 43,341 | 40,687 |
| Reference price 2 | 502.14 | 530.18 | 526.47 | 505.86 | 330.11 | 304.33 | 304.33 | 304.33 |
| Nbr of stocks (in thousands) | 9,41,851 | 9,34,349 | 9,24,925 | 9,20,284 | 9,05,839 | 9,07,676 | - | - |
| Announcement Date | 19/01/22 | 13/01/23 | 12/01/24 | 16/01/25 | 27/01/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 18.12x | 0.73x | 11.6x | 2.89% | 28TCr | ||
| 11.18x | 0.32x | 7.03x | 2.29% | 7.15TCr | ||
| 13x | 0.46x | 9.03x | 2.27% | 6.84TCr | ||
| 21.73x | 0.21x | 12.33x | 2.03% | 2.31TCr | ||
| 19.31x | 0.09x | 9.09x | -.--% | 1.83TCr | ||
| 44.71x | 0.16x | 10.21x | -.--% | 759.9Cr | ||
| 156.36x | 0.74x | 25.37x | -.--% | 418.81Cr | ||
| 13.95x | 0.81x | 4.77x | -.--% | 127.68Cr | ||
| -269.55x | 0.3x | 15.41x | -.--% | 101.26Cr | ||
| 48.18x | 2.71x | 14.27x | 0.58% | 29Cr | ||
| Average | 7.70x | 0.65x | 11.91x | 1.01% | 4.72TCr | |
| Weighted average by Cap. | 17.59x | 0.57x | 10.57x | 2.47% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- UNH Stock
- Valuation UnitedHealth Group Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















